Literature DB >> 12853837

Molecular targeting of VHL gene pathway in clear cell kidney cancer.

W Marston Linehan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12853837     DOI： 10.1097/01.ju.0000077210.05543.ae

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.

Authors:  Weifeng Zhong; Xiaohong Wang; Bin Pan; Zexuan Su
Journal:  Tumour Biol       Date:  2014-07-03

2.  THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy.

Authors:  Oktay Halit Aktepe; Fatma Gundogdu; Kemal Kosemehmetoglu; Haci Hasan Yeter; Sercan Aksoy; Deniz Can Guven; Taha Koray Sahin; Deniz Yuce; Neyran Kertmen; Omer Dizdar; Suayib Yalcin; Mustafa Erman
Journal:  Ir J Med Sci       Date:  2021-09-01       Impact factor: 2.089

Review 3.  Aerobic glycolysis: a novel target in kidney cancer.

Authors:  Brian Shuch; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Expert Rev Anticancer Ther       Date:  2013-06       Impact factor: 4.512

4.  TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.

Authors:  Mariano Francesco Caratozzolo; Alessio Valletti; Margherita Gigante; Italia Aiello; Francesca Mastropasqua; Flaviana Marzano; Pasquale Ditonno; Giuseppe Carrieri; Hélène Simonnet; Anna Maria D'Erchia; Elena Ranieri; Graziano Pesole; Elisabetta Sbisà; Apollonia Tullo
Journal:  Oncotarget       Date:  2014-09-15

5.  Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma.

Authors:  Yunxiang Gong; Degang Wang; Wengang Wang
Journal:  Comput Math Methods Med       Date:  2022-01-07       Impact factor: 2.238

Review 6.  A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.

Authors:  Daniel M Geynisman; Jodi K Maranchie; Mark W Ball; Gennady Bratslavsky; Eric A Singer
Journal:  Urol Oncol       Date:  2021-06-04       Impact factor: 2.954
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.